{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:56:53Z","timestamp":1790618213167,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Premature ovarian insufficiency (POI) affects 1\u20133.7% of women and causes infertility and long-term morbidity. Next-generation sequencing has identified more than 130 POI-associated genes. The diagnostic yield of genetic testing depends on cohort size and the quality and scope of the genetic analysis, reaching 29.3% in our largest international cohort reported to date. Major biological pathways involve meiosis\/DNA repair, follicular growth, and mitochondrial\/metabolic functions. Meiosis\/DNA-repair defects can impair fetal establishment of the ovarian reserve and, depending on the gene, variant, and allelic state, may be associated with chromosomal instability or cancer predisposition. This could enable early identification of selected at-risk patients, oncogenetic assessment, and cancer-prevention strategies. In contrast, alterations affecting follicular growth, metabolism, or mitochondrial function may be associated with persistence of a residual follicular pool, revealing a limited window of opportunity for timely fertility preservation in selected patients and at-risk relatives. Genetic diagnosis provides actionable information for etiological classification, and can reveal a syndromic condition, guide family screening, and, in selected genotypes, inform comorbidity assessment and early fertility preservation. It may also guide future mechanism-based therapies. By translating molecular findings into individualized reproductive and long-term care, POI provides a paradigmatic model of precision medicine in female infertility and reproductive endocrinology.<\/jats:p>","DOI":"10.3390\/ijms27198662","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:50:54Z","timestamp":1790614254000},"page":"8662","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-1863","authenticated-orcid":false,"given":"Vanessa","family":"Sousa","sequence":"first","affiliation":[{"name":"Cytogenetics Laboratory, School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal"},{"name":"Unit for Multidisciplinary Research in Biomedicine, School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Livera","sequence":"additional","affiliation":[{"name":"Stabilit\u00e9 G\u00e9n\u00e9tique Cellules Souches et Radiations, LDG\/iRCM\/IBFJ, Inserm, CEA, Universit\u00e9 Paris Cit\u00e9, F-92260 Fontenay-Aux-Roses, France"},{"name":"Stabilit\u00e9 G\u00e9n\u00e9tique Cellules Souches et Radiations, LDG\/iRCM\/IBFJ, Inserm, CEA, Universit\u00e9 Paris-Saclay, F-92260 Fontenay-Aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-8859","authenticated-orcid":false,"given":"Micheline","family":"Misrahi","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de G\u00e9n\u00e9tique Mol\u00e9culaire des Maladies M\u00e9taboliques et de la Reproduction, H\u00f4pital Bic\u00eatre AP-HP, H\u00f4pitaux Universitaires Paris-Saclay, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, 94275 Le Kremlin-Bicetre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tem.2018.03.010","article-title":"Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency","volume":"29","author":"Huhtaniemi","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"hoae065","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: Premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum. Reprod. Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/humrep\/deac014","article-title":"Incidence and familial risk of premature ovarian insufficiency in the Finnish female population","volume":"37","author":"Savukoski","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1210\/jc.2005-0181","article-title":"Heritability of age at natural menopause in the Framingham Heart Study","volume":"90","author":"Murabito","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"McGrath, I.M., Mortlock, S., and Montgomery, G.W. (2021). Genetic Regulation of Physiological Reproductive Lifespan and Female Fertility. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052556"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/humrep\/16.9.2014","article-title":"The role of genetic factors in age at natural menopause","volume":"16","author":"Bovenhuis","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/kwi324","article-title":"Age at natural menopause and cause-specific mortality","volume":"162","author":"Mondul","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.ede.0000165392.35273.d4","article-title":"Age at menopause, cause-specific mortality and total life expectancy","volume":"16","author":"Ossewaarde","year":"2005","journal-title":"Epidemiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2105\/AJPH.79.6.709","article-title":"Is early natural menopause a biologic marker of health and aging?","volume":"79","author":"Snowdon","year":"1989","journal-title":"Am. J. Public Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"251.e1","DOI":"10.1016\/j.ajog.2019.09.007","article-title":"Infertility and mortality","volume":"222","author":"Stentz","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","first-page":"100122","article-title":"Association of infertility with premature mortality among US women: Prospective cohort study","volume":"7","author":"Wang","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-021-03779-7","article-title":"Genetic insights into biological mechanisms governing human ovarian ageing","volume":"596","author":"Ruth","year":"2021","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: Management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104246","DOI":"10.1016\/j.ebiom.2022.104246","article-title":"Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine","volume":"84","author":"Heddar","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41436-021-01266-y","article-title":"Pathogenic variants of meiotic double strand break (DSB) formation genes PRDM9 and ANKRD31 in premature ovarian insufficiency","volume":"23","author":"Wang","year":"2021","journal-title":"Genet. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41591-022-02194-3","article-title":"Landscape of pathogenic mutations in premature ovarian insufficiency","volume":"29","author":"Ke","year":"2023","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Helbling-Leclerc, A., Falampin, M., Heddar, A., Guerrini-Rousseau, L., Marchand, M., Cavadias, I., Auger, N., Bressac-de Paillerets, B., Brugieres, L., and Lopez, B.S. (2024). Biallelic Germline BRCA1 Frameshift Mutations Associated with Isolated Diminished Ovarian Reserve. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212460"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2019-106672","article-title":"Homozygous hypomorphic BRCA2 variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait","volume":"58","author":"Caburet","year":"2020","journal-title":"J. Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJMoa1800024","article-title":"Essential Role of BRCA2 in Ovarian Development and Function","volume":"379","author":"Rachmiel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jgg.2023.03.013","article-title":"Rare variants in FANCJ induce premature ovarian insufficiency in humans and mice","volume":"51","author":"Yang","year":"2024","journal-title":"J. Genet. Genom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41588-024-01885-6","article-title":"Homozygosity for a stop-gain variant in CCDC201 causes primary ovarian insufficiency","volume":"56","author":"Oddsson","year":"2024","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105718","DOI":"10.1016\/j.ebiom.2025.105718","article-title":"CKAP5 deficiency induces premature ovarian insufficiency","volume":"115","author":"Hu","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1210\/clinem\/dgac528","article-title":"Premature Ovarian Insufficiency in CLPB Deficiency: Transcriptomic, Proteomic and Phenotypic Insights","volume":"107","author":"Tucker","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00439-021-02319-7","article-title":"New insights into Perrault syndrome, a clinically and genetically heterogeneous disorder","volume":"141","author":"Faridi","year":"2022","journal-title":"Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajhg.2024.11.007","article-title":"Bi-allelic variants in DAP3 result in reduced assembly of the mitoribosomal small subunit with altered apoptosis and a Perrault-syndrome-spectrum phenotype","volume":"112","author":"Smith","year":"2025","journal-title":"Am. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"lnae007","DOI":"10.1093\/lifemedi\/lnae007","article-title":"Truncated DAZL mutation reduces NANOS3 expression in primordial germ cells and leads to premature ovarian insufficiency","volume":"3","author":"Liu","year":"2024","journal-title":"Life Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/biolre\/ioae148","article-title":"Functional characterization of human recessive DIS3 variants in premature ovarian insufficiency","volume":"112","author":"Kline","year":"2025","journal-title":"Biol. Reprod."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lafraoui, I., Heddar, A., Cantalloube, A., Braham, I., Peign\u00e9, M., Beneteau, C., Gricourt, S., Poirsier, C., Legrand, S., and Stoeva, R. (2024). Genetic Landscape of a Cohort of 120 Patients with Diminished Ovarian Reserve: Correlation with Infertility. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252211915"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00439-019-02059-9","article-title":"Rare variants in FANCA induce premature ovarian insufficiency","volume":"138","author":"Yang","year":"2019","journal-title":"Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00439-024-02650-9","article-title":"Novel compound heterozygous variants in FANCI cause premature ovarian insufficiency","volume":"143","author":"Cao","year":"2024","journal-title":"Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e30490","DOI":"10.7554\/eLife.30490","article-title":"A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency","volume":"6","author":"Fouquet","year":"2017","journal-title":"eLife"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e191122","DOI":"10.1172\/jci.insight.191122","article-title":"Genetic variants in HELB contribute to premature ovarian insufficiency and early age of natural menopause","volume":"10","author":"Pan","year":"2025","journal-title":"JCI Insight"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jgg.2025.12.005","article-title":"MEI4 variations drive female reproductive disorders via impaired oocyte abundance and developmental potential","volume":"53","author":"Wang","year":"2026","journal-title":"J. Genet. Genom."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e183758","DOI":"10.1172\/JCI183758","article-title":"MGA loss-of-function variants cause premature ovarian insufficiency","volume":"134","author":"Tang","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ajhg.2025.02.005","article-title":"Bi-allelic variants in MRPL49 cause variable clinical presentations, including sensorineural hearing loss, leukodystrophy, and ovarian insufficiency","volume":"112","author":"Thomas","year":"2025","journal-title":"Am. J. Hum. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00439-023-02563-z","article-title":"Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency","volume":"142","author":"Bakhshalizadeh","year":"2023","journal-title":"Hum. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jmedgenet-2020-107398","article-title":"Haploinsufficiency in non-homologous end joining factor 1 induces ovarian dysfunction in humans and mice","volume":"59","author":"Li","year":"2022","journal-title":"J. Med. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00415-024-12838-8","article-title":"Novel PNPLA8 variants associated with primary ovarian insufficiency, tremors, cerebellar ataxia and limb weakness: A case report and literature review","volume":"272","author":"Chen","year":"2024","journal-title":"J. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"ugae010","DOI":"10.1093\/narmme\/ugae010","article-title":"The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome","volume":"1","author":"Witham","year":"2024","journal-title":"NAR Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.gim.2021.09.019","article-title":"Pathogenic variants in RNPC3 are associated with hypopituitarism and primary ovarian insufficiency","volume":"24","author":"Akin","year":"2022","journal-title":"Genet. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cge.14080","article-title":"A SPIDR homozygous nonsense pathogenic variant in isolated primary ovarian insufficiency with chromosomal instability","volume":"101","author":"Heddar","year":"2022","journal-title":"Clin. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/humrep\/deaf177","article-title":"SWS1-complex in premature ovarian insufficiency: SWSAP1 as a new POI gene","volume":"40","author":"Lokchine","year":"2025","journal-title":"Hum. Reprod."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00439-021-02380-2","article-title":"A recessive variant in TFAM causes mtDNA depletion associated with primary ovarian insufficiency, seizures, intellectual disability and hearing loss","volume":"140","author":"Ullah","year":"2021","journal-title":"Hum. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e154671","DOI":"10.1172\/jci.insight.154671","article-title":"Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency","volume":"7","author":"Bellutti","year":"2022","journal-title":"JCI Insight"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e64078","DOI":"10.1002\/ajmg.a.64078","article-title":"Compound Heterozygous Variants in ZSWIM7 Gene Linked to Infertility and Its Role in Gonadal Development","volume":"197","author":"Christofolini","year":"2025","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/clinem\/dgab775","article-title":"Causal and Candidate Gene Variants in a Large Cohort of Women with Primary Ovarian Insufficiency","volume":"107","author":"Gorsi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mej\u00eda-Barrera, M.A., Mart\u00ednez-Torres, E.E., Ju\u00e1rez-Figueroa, U., Torres, L., Fiesco-Roa, M.O., Garc\u00eda-de-Teresa, B., Gomez-Verjan, J.C., Mel\u00e9ndez-Zajgla, J., Rodr\u00edguez, A., and S\u00e1nchez, S. (2026). The tight bond between Fanconi anemia and aging. Front. Aging, 7.","DOI":"10.3389\/fragi.2026.1752160"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2501089","DOI":"10.1200\/PO-25-01089","article-title":"Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in FANCM-Associated Fanconi Anemia","volume":"10","author":"Pegoraro","year":"2026","journal-title":"JCO Precis. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-16-2568","article-title":"BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer","volume":"77","author":"Shimelis","year":"2017","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJMc1813800","article-title":"BRCA2 in Ovarian Development and Function","volume":"380","author":"Turchetti","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A Population-Based Study of Genes Previously Implicated in Breast Cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0165-4608(96)00336-6","article-title":"Bloom\u2019s syndrome. XX. The first 100 cancers","volume":"93","author":"German","year":"1997","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s44276-025-00199-2","article-title":"A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2","volume":"3","author":"Grindedal","year":"2025","journal-title":"BJC Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"djv214","DOI":"10.1093\/jnci\/djv214","article-title":"Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women with Ovarian Cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2002-05-1498","article-title":"Cancer incidence in persons with Fanconi anemia","volume":"101","author":"Rosenberg","year":"2003","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/clinem\/dgaa155","article-title":"A Novel Phenotype Combining Primary Ovarian Insufficiency Growth Retardation and Pilomatricomas With MCM8 Mutation","volume":"105","author":"Heddar","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"106737","DOI":"10.1016\/j.isci.2023.106737","article-title":"Molecular functions of MCM8 and MCM9 and their associated pathologies","volume":"26","author":"Helderman","year":"2023","journal-title":"iScience"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41525-021-00242-4","article-title":"MCM9 is associated with germline predisposition to early-onset cancer\u2014Clinical evidence","volume":"6","author":"Goldberg","year":"2021","journal-title":"npj Genom. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","article-title":"Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options\u2014A Retrospective Analysis","volume":"35","author":"Gregorek","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jnci\/95.9.669","article-title":"Association Between Osteosarcoma and Deleterious Mutations in the RECQL4 Gene in Rothmund-Thomson Syndrome","volume":"95","author":"Wang","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa1309635","article-title":"Mutant cohesin in premature ovarian failure","volume":"370","author":"Caburet","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_64","first-page":"239","article-title":"Excess of rare cancers in Werner syndrome (adult progeria)","volume":"5","author":"Goto","year":"1996","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jmedgenet-2016-103847","article-title":"Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene","volume":"53","author":"Park","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/humupd\/dmaa034","article-title":"Molecular genetics of infertility: Loss-of-function mutations in humans and corresponding knockout\/mutated mice","volume":"27","author":"Jiao","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jc.2016-2046","article-title":"Cancer Risks in Patients Treated with Growth Hormone in Childhood: The SAGhE European Cohort Study","volume":"102","author":"Swerdlow","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mce.2007.11.017","article-title":"Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure","volume":"282","author":"Massin","year":"2008","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/jc.2011-1038","article-title":"Resumption of Ovarian Function and Pregnancies in 358 Patients with Premature Ovarian Failure","volume":"96","author":"Bidet","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Vo, K.C.T., and Kawamura, K. (2021). In Vitro Activation Early Follicles: From the Basic Science to the Clinical Perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073785"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"eadz4075","DOI":"10.1126\/science.adz4075","article-title":"Antifibrotic drug finerenone restores fertility in premature ovarian insufficiency","volume":"391","author":"Lin","year":"2026","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1097\/JS9.0000000000004655","article-title":"Multi-target modulation of the homologous recombination pathway by resveratrol promotes DNA damage repair in POI: Integrated network pharmacology, molecular dynamics simulation, and experimental validation","volume":"112","author":"Yu","year":"2026","journal-title":"Int. J. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1210\/jc.2003-030217","article-title":"Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: Clinical, histological, and molecular studies","volume":"88","author":"Meduri","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mce.2007.11.027","article-title":"Molecular pathology of the FSH receptor: New insights into FSH physiology","volume":"282","author":"Meduri","year":"2008","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"104733","DOI":"10.1016\/j.rbmo.2024.104733","article-title":"Women with FSHR-inactivating mutations causing resistant ovarian syndrome benefit from oocyte in-vitro maturation","volume":"50","author":"Li","year":"2025","journal-title":"Reprod. Biomed. Online"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/humupd\/dmu036","article-title":"The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders","volume":"20","author":"Persani","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cge.12970","article-title":"BMP15 \u201cknockout-like\u201d effect in familial premature ovarian insufficiency with persistent ovarian reserve","volume":"92","author":"Mayer","year":"2017","journal-title":"Clin. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/humrep\/dead066","article-title":"Association of genetic disorders and congenital malformations with premature ovarian insufficiency: A nationwide register-based study","volume":"38","author":"Savukoski","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.metabol.2018.01.025","article-title":"Hereditary galactosemia","volume":"83","author":"Demirbas","year":"2018","journal-title":"Metabolism"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2017.05.013","article-title":"Fertility in adult women with classic galactosemia and primary ovarian insufficiency","volume":"108","author":"Berry","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"lvad018","DOI":"10.1093\/ejendo\/lvad018","article-title":"Family building after diagnosis of premature ovarian insufficiency: A cross-sectional survey in 324 women","volume":"188","author":"Cambray","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.rbmo.2019.04.019","article-title":"Pregnancy following diagnosis of premature ovarian insufficiency: A systematic review","volume":"39","author":"Fraison","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"101183","DOI":"10.1016\/j.lanepe.2024.101183","article-title":"PFMG2025-integrating genomic medicine into the national healthcare system in France","volume":"50","author":"Abadie","year":"2025","journal-title":"Lancet Reg. Health Eur."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8662\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:04:23Z","timestamp":1790615063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":83,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198662"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198662","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}